Cervical Cancer Awareness Month

In January, the WHO-recognized Cervical Cancer Awareness Month features global activities to raise awareness and support for Cervical Cancer research. We would like to take this opportunity to extend our appreciation to all of the researchers who have contributed to the fight against this disease. In particular, we would like to share some of the high-quality and innovative research findings in the field of Cervical Cancer that have been published in MDPI’s Journal Cluster of Oncology: Cancers, Current Oncology, Onco and Targets. We hope this announcement will provide useful information for all individuals interested in this field.

“Long-Term Outcomes of Co-Testing with 3-Type HPV mRNA (16/18/45) and Cytology in Women Under 40: A Real-World Cohort from Northern Norway (8–10 Years of Follow-Up)”
by Marie Bostrøm, Gunnar Skov Simonsen and Sveinung Wergeland Sørbye
Targets 2025, 3(4), 36; https://doi.org/10.3390/targets3040036

“The Role of Tissue Factor-Positive Microparticles in Gynecological Cancer-Associated Disseminated Intravascular Coagulation: Molecular Mechanisms and Clinical Implications”
by Muqaddas Qureshi, Muhammad Tanveer Alam and Ahsanullah Unar
Onco 2025, 5(3), 33; https://doi.org/10.3390/onco5030033

“The Neutrophil-to-Lymphocyte Ratio (NLR) as a Potential Predictor in Conization Outcomes for Cervical Cancer”
by Balázs Vida, Emese Keszthelyi, Zsófia Tóth, Lotti Lőczi, Barbara Sebők, Petra Merkely, Balázs Lintner, Ferenc Bánhidy, Attila Keszthelyi, Szabolcs Várbíró, Richárd Tóth and Márton Keszthelyi
Cancers 2025, 17(11), 1856; https://doi.org/10.3390/cancers17111856

“A Systematic Review of SBRT Boost for Cervical Cancer Patients Who Cannot Benefit from Brachytherapy”
by Iozsef Gazsi and Loredana G. Marcu
Curr. Oncol. 2025, 32(3), 170; https://doi.org/10.3390/curroncol32030170

“Neutrophil/Lymphocyte Ratio (NLR) as a Predictive Marker for p16 Positivity and Cervical Cancer Progression: Insights from the SCOPE Study”
by Zsófia Tóth, Lotti Lőczi, Barbara Sebők, Petra Merkely, Emese Keszthelyi, Balázs Lintner, Nándor Ács, Attila Keszthelyi, Szabolcs Várbíró, Richárd Tóth et al.
Cancers 2025, 17(6), 921; https://doi.org/10.3390/cancers17060921

“Molecular Insights into HR-HPV and HCMV Co-Presence in Cervical Cancer Development”
by Rancés Blanco and Juan P. Muñoz
Cancers 2025, 17(4), 582; https://doi.org/10.3390/cancers17040582

“Management for Cervical Cancer Patients: A Comparison of the Guidelines from the International Scientific Societies (ESGO-NCCN-ASCO-AIOM-FIGO-BGCS-SEOM-ESMO-JSGO)”
by Stefano Restaino, Giulia Pellecchia, Martina Arcieri, Giorgio Bogani, Cristina Taliento, Pantaleo Greco, Lorenza Driul, Vito Chiantera, Alfredo Ercoli, Francesco Fanfani et al.
Cancers 2024, 16(14), 2541; https://doi.org/10.3390/cancers16142541

“Impact of PET/CT Imaging with FDG in Locally Advanced Cervical Carcinoma—A Literature Review”
by Ottó Molnar, Oreste Mihai Straciuc, Simona Mihuțiu and Liviu Lazăr
Curr. Oncol. 2024, 31(5), 2508-2526; https://doi.org/10.3390/curroncol31050188

“The Role of Imaging in Cervical Cancer Staging: ESGO/ESTRO/ESP Guidelines (Update 2023)”
by Daniela Fischerova, Filip Frühauf, Andrea Burgetova, Ingfrid S. Haldorsen, Elena Gatti and David Cibula
Cancers 2024, 16(4), 775; https://doi.org/10.3390/cancers16040775 

“Fertility Preservation in Cervical Cancer—Treatment Strategies and Indications”
by Lina Salman and Allan Covens
Curr. Oncol. 2024, 31(1), 296-306; https://doi.org/10.3390/curroncol31010019

“Cervical Cancer Screening: Current Practices and Future Perspectives” Guest Editor: Dr. Kimon Chatzistamatiou Submission deadline: 20 March 2026	“Clinical Management of Cervical Cancer” Guest Editor: Dr. Vanessa Samouëlian Submission deadline: 31 March 2026
“The Role of Minimally Invasive and Minimally Radical Surgery in Cervical and Endometrial Cancer” Guest Editors: Dr. Raj Naik, Dr. Marie Plante, Dr. Christophe Pomel, Prof. Dr. Roberto Tozzi and Dr. Gwénaël Ferron Submission deadline: 1 September 2026	“Medical Image-Based Cervical Cancer Prevention, Diagnosis, and Treatment” Guest Editors: Dr. Emma R. Allanson and Dr. Ming Yin Lin Submission deadline: 30 September 2026

 

“Gynaecological Cancers Risk: Breast Cancer, Ovarian Cancer and Endometrial Cancer” Edited by Ranjit Manchanda https://doi.org/10.3390/books978-3-0365-2983-7 This is a Reprint of the Special Issue Gynaecological Cancers Risk: Breast Cancer, Ovarian Cancer and Endometrial Cancer that was published in Cancers.